Drugs & Targets FDA approves betrixaban for the prophylaxis of venous thromboembolism in adult patients June 23, 2017Vol.43 No.25
Drugs & Targets FDA accepts Amgen’s application to expand indication for Xgeva June 23, 2017Vol.43 No.25
Drugs & Targets FDA approves Darzalex as combination therapy for multiple myeloma June 16, 2017Vol.43 No.24
Drugs & Targets FDA approves aminolevulinic acid hydrochloride as imaging agent for gliomas June 16, 2017Vol.43 No.24
Drugs & Targets OncoSec granted orphan drug designation for unresectable metastatic melanoma June 16, 2017Vol.43 No.24
Drugs & Targets BMS, Novartis announce collaboration focused on metastatic colorectal cancer June 09, 2017Vol.43 No.23
Drugs & Targets Roche announces FDA approval of companion diagnostic to identify ALK-positive non-small cell lung cancer patients June 09, 2017Vol.43 No.23
Drugs & Targets Amgen and Allergan announce FDA advisory committee meeting to review ADP 215, a biosimilar candidate to Bevacizumab June 09, 2017Vol.43 No.23
Drugs & Targets Hitachi and MD Anderson to collaborate in research in oropharyngeal cancer June 09, 2017Vol.43 No.23
